Jinhong Zhang

Jinhong Zhang

Auto-generated profile, based on publicly available information

Jinhong Zhang

Department of Otolaryngology School of Medicine, South China University of Technology Guangzhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
JZJinhong Zhang
Jinhong Zhang
JLJinrang Li
Jinrang Li
YZYanping Zhang
Yanping Zhang
QNQian Nie
Qian Nie
RZRan Zhang
Ran Zhang
LLLina Li
Lina Li
Objective: To study the value of multitime point salivary pepsin testing (MTPSPT) for the diagnosis of laryngopharyngeal reflux (LPR).Study Design: Prospective noncontrolled.Methods: For patients who met the enrollment criteria, the reflux symptom index (RSI) and reflux finding score (RFS) were calculated and salivary pepsin testing was performed. The pepsin test was performed every hour from 7:00 a.m. to 6:00 p.m. by collecting fresh saliva samples. A single positive test result was needed for the diagnosis of LPR. The consistency in the diagnosis of LPR between the two methods was compared with the weighted Cohen's kappa statistic.Results: A total of 204 patients were included. The kappa value between the two methods was 0.566 (p = .00). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of MTPSPT were 76.43%, 85.94%, 92.24%, and 62.5%, respectively. We also compared a single pepsin measure at 7 a.m. with the screening results based on the RSI and RFS, and found a much lower kappa agreement value (0.223, p = .00). The sensitivity, specificity, PPV, NPV, and false‐negative rate of pepsin testing at 7 a.m. (fasting) were 37.86%, 92.18%, 91.38%, 40.41%, and 58.57%, respectively.Conclusion: The use of the result of a single salivary pepsin test in the morning yields a relatively higher rate of missed diagnosis of LPR, and multitime point testing through a day increased the accuracy and sensitivity of detection of LPR twofold compared to a single morning fasting sample.Level of Evidence: 3

1 December 2022 in The Laryngoscope
Verified
Journal Article
Closed access
CZChun Zhang
Chun Zhang
ZLZhi Liu
Zhi Liu
JZJinhong Zhang
Jinhong Zhang
XWXiaoyu Wang
Xiaoyu Wang
JWJiasen Wang
Jiasen Wang
LLLianLian Liu
LianLian Liu

23 September 2022 in The Laryngoscope
Verified
Journal Article
Closed access
JZJinhong Zhang
Jinhong Zhang
XWXiaoyu Wang
Xiaoyu Wang
JWJiasen Wang
Jiasen Wang
JZJing Zhao
Jing Zhao
CZChun Zhang
Chun Zhang
JLJinrang Li
Jinrang Li

2 November 2022 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
YPYufei Pan
Yufei Pan
JLJinrang Li
Jinrang Li
XWXiaoyu Wang
Xiaoyu Wang
JZJinhong Zhang
Jinhong Zhang
CZChun Zhang
Chun Zhang
ZLZhi Liu
Zhi Liu
Objective: This study aimed to develop an objective and simple score for predicting the prognosis of patients with laryngeal contact granuloma (LCG) treated with local glucocorticoid injection combined with oral proton pump inhibitor (GI + PPI).Methods: Cox regression analysis was used to analyze the effect of baseline variables on the prognosis of 507 patients with LCG treated with GI + PPI. An easy‐to‐apply RCGSG (Reflus, Cough, Gender, and Surgery in GI + PPI therapy) score was developed based on the independent risk factors selected by univariate and multivariate Cox regression analyses. The score was internally validated by receiver‐operating characteristic curve, calibration curve, and decision curve analysis.Results: After univariate and multivariate analyses, male gender (hazard ratio [HR] 0.546, p < .001), laryngopharyngeal reflux (HR 0.702, p = .001), chronic cough (HR 0.709, p = .001), and history of surgical resection (HR 0.433, p < .001) were found to be the independent risk factors affecting the prognosis of LCG. According to the score, the median cure time was 3 months (95% confidence interval [CI] 2.81–3.19) in the low‐risk group, 4 months (95% CI 3.74–4.26) in the moderate‐risk group, and 5 months (95% CI 4.76–5.24) in the high‐risk group. The bootstrap method was used to plot calibration curves for internal validation.Conclusion: The RCGSG score, developed based on laryngopharyngeal reflux, chronic cough, gender, and surgical resection history, has been internally verified to be a good predictor of the prognosis of patients with LCG receiving GI + PPI treatment.Level of evidence: Level 4.

2 September 2022 in Journal of Voice
Verified
Journal Article
Closed access
PDF file
JZJinhong Zhang
Jinhong Zhang
XWXiaoyu Wang
Xiaoyu Wang
JWJiasen Wang
Jiasen Wang
JZJing Zhao
Jing Zhao
CZChun Zhang
Chun Zhang
JLJinrang Li
Jinrang Li